Ba MC - Search Results

1

Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer.

Ba MC, Long H, Zhang XL, Gong YF, Tang YQ, Wu YB, Yu FH, Cui SZ. Ba MC, et al. J Laparoendosc Adv Surg Tech A. 2016 Jan;26(1):32-9. doi: 10.1089/lap.2015.0266. J Laparoendosc Adv Surg Tech A. 2016. PMID: 26779722 Clinical Trial.

2

Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy.

Ba MC, Long H, Zhang XL, Gong YF, Yan ZF, Wang S, Tang YQ, Cui SZ. Ba MC, et al. Yonsei Med J. 2017 May;58(3):497-504. doi: 10.3349/ymj.2017.58.3.497. Yonsei Med J. 2017. PMID: 28332353 Free PMC article.

3

B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.

Cui S, Ba M, Tang Y, Liu J, Wu Y, Wang B, Zhang X, Tang H, Zhong S. Cui S, et al. Oncol Rep. 2012 Oct;28(4):1325-31. doi: 10.3892/or.2012.1913. Epub 2012 Jul 13. Oncol Rep. 2012. PMID: 22797826 Clinical Trial.

4

Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion.

Ba M, Long H, Wang Y, Tang Y, Wu Y, Zhang X, Cui S. Ba M, et al. J Cancer Res Clin Oncol. 2013 Dec;139(12):2005-12. doi: 10.1007/s00432-013-1526-x. Epub 2013 Sep 26. J Cancer Res Clin Oncol. 2013. PMID: 24072234 Clinical Trial.

5

Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites.

Ba M, Long H, Zhang X, Tang Y, Wu Y, Yu F, Wang S, Cui S. Ba M, et al. J Cancer Res Clin Oncol. 2014 Sep;140(9):1497-506. doi: 10.1007/s00432-014-1692-5. Epub 2014 May 22. J Cancer Res Clin Oncol. 2014. PMID: 24849730 Clinical Trial.

6

Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer.

Ba M, Long H, Zhang X, Tang Y, Wu Y, Wang S, Yan Z, Zhang B, Cui S. Ba M, et al. Int J Gynecol Cancer. 2016 Nov;26(9):1571-1579. doi: 10.1097/IGC.0000000000000809. Int J Gynecol Cancer. 2016. PMID: 27779544 Clinical Trial.

7

Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.

Ba M, Cui S, Wang B, Long H, Yan Z, Wang S, Wu Y, Gong Y. Ba M, et al. Oncol Rep. 2017 May;37(5):2761-2770. doi: 10.3892/or.2017.5570. Epub 2017 Apr 11. Oncol Rep. 2017. PMID: 28405683 Clinical Trial.

8

Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy.

Ba M, Long H, Zhang X, Yan Z, Wang S, Wu Y, Gong Y, Cui S. Ba M, et al. Oncol Lett. 2019 Aug;18(2):2025-2033. doi: 10.3892/ol.2019.10493. Epub 2019 Jun 19. Oncol Lett. 2019. PMID: 31423274 Free PMC article.

9

Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study.

Ba M, Cui S, Long H, Gong Y, Wu Y, Lin K, Tu Y, Zhang B, Wu W. Ba M, et al. BMC Urol. 2019 Dec 3;19(1):126. doi: 10.1186/s12894-019-0543-8. BMC Urol. 2019. PMID: 31795980 Free PMC article. Clinical Trial.

10

Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study.

Ba M, Chen C, Long H, Gong Y, Wu Y, Lin K, Tu Y, Zhang B, Wu W. Ba M, et al. Medicine (Baltimore). 2020 Aug 14;99(33):e21546. doi: 10.1097/MD.0000000000021546. Medicine (Baltimore). 2020. PMID: 32872001 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters